On Friday, August 25th, Kings County Hospital celebrated the dedication of their 360-square-foot, $1.3 million Positron Emission Tomography (PET) diagnostic imagery facility, one of the hospital's Centers of Excellence. This represents the first PET center within HHC.
PET is a non-invasive, diagnostic imaging technique for measuring the metabolic activity of cells in the human body. Providing images of the body's basic biochemistry, PET is useful in the diagnosis and management of many patients with cancer, certain neurological disorders, and heart disease. Earlier, more accurate diagnosis of these conditions with PET has resulted in HCFA endorsement for Medicare reimbursement of PET clinical studies in most situations.
PET scans are the procedure of choice in staging and monitoring therapy of various lung cancers, lymphoma, melanoma, head and neck cancer, colorectal cancer, pancreatic cancer, thyroid cancer, esophageal cancer, breast cancer and multiple myeloma.
Usually PET facilities require the use of expensive cyclotrons, however, Fluorine-18 labeled fluorodeoxyglucose (FOG), the agent of choice for staging cancer and Alzheimer's disease, is commercially available in NYC from several vendors on a cost-per-dose basis.
A broad human-use radioactive materials license at Kings is already in place, permitting the hospital to start clinical studies upon NYSOOH approval.